MIFLONIL BREEZHALER 200 microgrammes, poudre pour inhalation en gélule — plaquettes PVC PVDC aluminium de 60 gélules avec inhalateur Breezhaler

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930178874
  • CIP7 3017887
  • CIS 67403357

What the source publishes

Holder
NOVARTIS PHARMA
Active ingredients
BUDÉSONIDE
Form
poudre pour inhalation en gélule
Package
plaquettes PVC PVDC aluminium de 60 gélules avec inhalateur Breezhaler
Routes
inhalée
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2019-05-24
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930178874
{
  "cis": "67403357",
  "cip7": "3017887",
  "form": "poudre pour inhalation en gélule",
  "name": "MIFLONIL BREEZHALER 200 microgrammes, poudre pour inhalation en gélule — plaquettes PVC PVDC aluminium de 60 gélules avec inhalateur Breezhaler",
  "cip13": "3400930178874",
  "holder": "NOVARTIS PHARMA",
  "routes": [
    "inhalée"
  ],
  "holders": [
    "NOVARTIS PHARMA"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "6.95",
  "authorisedOn": "2019-05-24",
  "compositions": [
    {
      "name": "BUDÉSONIDE",
      "nature": "SA",
      "strength": "200 microgrammes",
      "linkageNumber": "1",
      "substanceCode": "24381",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "5.93",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "MIFLONIL BREEZHALER 200 microgrammes, poudre pour inhalation en gélule",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquettes PVC PVDC aluminium de 60 gélules avec inhalateur Breezhaler",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2025-02-06",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "BUDÉSONIDE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930178874"